Hibah Khaja, PharmD

Researchers conducted a systematic review to analyze published literature on the management of dysphagia among patients with inclusion body myositis.

The risk for fractures were compared among women with osteoporosis receiving gastro-resistant vs immediate-release risedronate or alendronate.